A phase IIb trial of MVAHIV62 for the prevention of HIV infections in high-risk subjects

Trial Profile

A phase IIb trial of MVAHIV62 for the prevention of HIV infections in high-risk subjects

Planning
Phase of Trial: Phase II

Latest Information Update: 16 Mar 2016

At a glance

  • Drugs GOVX-B11 (Primary) ; MVA-HIV62 (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Mar 2016 This trial is expected to begin in mid-2016, according to a GeoVax media release.
    • 16 Mar 2016 Planned initiation date changed from 1 Jun 2015 to 1 Jul 2016, according to a GeoVax media release.
    • 13 May 2015 Planned initiation date changed from 1 Jun 2014 to 1 Jun 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top